Cyclacel Pharmaceuticals, Inc. announces private placement of 7,956 shares of common stock at an issue price of $3.315 per share and warrants to purchase up to 7,956 shares of common stock with an exercise price of $3.19 per share to members of management for gross proceeds of $26,374.14 on December 22, 2023. The transaction is expected to close on December 26, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.07 USD | +3.50% | +52.21% | -22.47% |
May. 02 | Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding | CI |
Apr. 30 | Top Midday Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.47% | 2.64M | |
+9.15% | 105B | |
-1.08% | 104B | |
+5.79% | 22.94B | |
-11.55% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.91% | 16.96B | |
+7.55% | 14.16B | |
+40.04% | 12.63B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Cyclacel Pharmaceuticals, Inc. announced that it expects to receive $0.026374 million in funding